microRNA

Yuan-Yuan Lu1, Yi Li2, Zhi-Li Chen3

  • 1Institutes of Physical Science and Information Technology, Anhui University, Hefei, 230000, China; Academy of Military Medical Sciences, Beijing, 100850, China.

PubMed
概括

这项研究开发了一种用于肝细胞癌 (HCC) 治疗的新型遗传开关. 该系统精确地向癌细胞,显著降低活力,同时节省健康细胞,提高基于miRNA的治疗安全性.